Clinical Policy: Sodium Oxybate (Xyrem)
Customize your policy alerts
Sign up for Arizona Complete Health Policy AZ.CP.PMN.42 alerts
Get alerted when Policy AZ.CP.PMN.42 changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and medical-necessity coverage of Xyrem for Arizona Medicaid members with narcolepsy-related cataplexy or excessive daytime sleepiness. It establishes diagnostic, specialist, age, step-therapy, dose, documentation, and continuation requirements.
A one-month trial and failure of armodafinil or modafinil is now required for members age 17 or older with narcolepsy and excessive daytime sleepiness.
Care1st logo content and clarifying wording were added.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.